Clinical and Biochemical Evaluation of the Efficacy of Non-Surgical Treatment Approaches in the Treatment of Peri-implantitis
1 other identifier
interventional
46
1 country
1
Brief Summary
Peri-implantitis is a pathological condition associated with plaque that develops around dental implants, characterized by inflammation and progressive bone loss in the peri-implant area. Bleeding on probing, suppuration, increased pathological pocket depths and/or mucosal recessions are seen with radiographic bone loss in peri-implantitis. When evaluated histologically, the lesion extends to the apical part of the pocket epithelium and contains a large amount of plasma cells, macrophages and neutrophils. In the Peri-implant crevicular fluid analysis, which is one of the most important parameters that enable the biochemical and immunological evaluation of the inflammatory state in the peri-implant region, information about the current inflammatory situation can be obtained by evaluating the content of an osmotic inflammatory exudate originating from the vessels in the gingival plexus. Many surgical and non-surgical methods have been proposed for the treatment of peri-implantitis. Mechanical surface debridement, laser application and air abrasives are a part of non-surgical treatment of peri-implantitis. In this study, we examined the effectiveness of diode laser in addition to mechanical debridement with titanium curettes. In our study, we aimed to compare these two treatments biochemically by determining the changes in interleukin-1β, Interleukin-10, Interleukin-17, RANKL, osteoprotegerin, TWEAK and sclerostin biomarkers in Peri-implant crevicular fluid and clinically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2018
CompletedFirst Submitted
Initial submission to the registry
October 12, 2021
CompletedFirst Posted
Study publicly available on registry
January 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedMarch 2, 2022
February 1, 2022
3.4 years
October 12, 2021
February 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical parameter probing depth
The primary outcome of the study was the control examination performed 3 months after the first examination. Probing depth was measured with a periodontal probe by the distance between gingival margin and the base of the pocket. The change between these time frames are recorded.
Baseline, 3 months and 6 months
Secondary Outcomes (5)
Another outcome of the study is the collection of gingival crevicular fluid samples in the 3rd month.
Baseline, 3 months and 6 months
Gingival bleeding time index
Baseline, 3 months and 6 months
Gingival index
Baseline, 3 months and 6 months
Plaque index
Baseline, 3 months and 6 months
Clinical attachment level
Baseline, 3 months and 6 months
Study Arms (2)
Diode Laser
EXPERIMENTALAt baseline, diode laser is applied to one group.
Titanium curettes
ACTIVE COMPARATORAt baseline, titanium curettes are used to both of the groups
Interventions
Non-surgical treatment with titanium curettes were administrated to both groups.
Eligibility Criteria
You may qualify if:
- Presence of 5mm or more peri-implant pockets
- Not having periodontal treatment in the last 3 months,
- The informed consent form must be approved,
- At least 18 years old.
You may not qualify if:
- Presence of systemic disease,
- Smoking,
- Regular use of non-steroidal anti inflammatory drugs,
- Having been treated with antibiotics in the last 3 months,
- Individuals in need of pre-treatment antibiotic prophylaxis,
- Pregnancy and lactation,
- Not approving the informed consent form,
- Patients with known allergies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Güliz Nigar GÜNCÜ, Prof. Dr.
study director
- PRINCIPAL INVESTIGATOR
Abdullah Cevdet AKMAN, Prof Dr
Principal Investigator
- PRINCIPAL INVESTIGATOR
Rahime Meral NOHUTCU
Principal Investigator
- PRINCIPAL INVESTIGATOR
Ali Tuğrul GÜR, Phd
Principal Investigator
- PRINCIPAL INVESTIGATOR
Aslı PINAR, Prof Dr
biochemistry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
October 12, 2021
First Posted
January 21, 2022
Study Start
November 12, 2018
Primary Completion
April 1, 2022
Study Completion
October 1, 2022
Last Updated
March 2, 2022
Record last verified: 2022-02